DK0835659T3 - Anvendelse af ikke-peptidiske antagonister for bradykinin til fremstilling af lægemidler til behandling og forebyggelse af Alzheimer's sygdom - Google Patents

Anvendelse af ikke-peptidiske antagonister for bradykinin til fremstilling af lægemidler til behandling og forebyggelse af Alzheimer's sygdom

Info

Publication number
DK0835659T3
DK0835659T3 DK97117677T DK97117677T DK0835659T3 DK 0835659 T3 DK0835659 T3 DK 0835659T3 DK 97117677 T DK97117677 T DK 97117677T DK 97117677 T DK97117677 T DK 97117677T DK 0835659 T3 DK0835659 T3 DK 0835659T3
Authority
DK
Denmark
Prior art keywords
alkyl
aryl
alkoxy
alzheimer
disease
Prior art date
Application number
DK97117677T
Other languages
English (en)
Inventor
Holger Heitsch
Gabriele Wiemer
Klaus Wirth
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1996142290 external-priority patent/DE19642290A1/de
Priority claimed from DE1997129140 external-priority patent/DE19729140A1/de
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK0835659T3 publication Critical patent/DK0835659T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Quinoline Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
DK97117677T 1996-10-14 1997-10-13 Anvendelse af ikke-peptidiske antagonister for bradykinin til fremstilling af lægemidler til behandling og forebyggelse af Alzheimer's sygdom DK0835659T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1996142290 DE19642290A1 (de) 1996-10-14 1996-10-14 Verwendung von nicht-peptidischen Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von Prävention der Alzheimer'schen Krankheit
DE1997129140 DE19729140A1 (de) 1997-07-08 1997-07-08 Verwendung von nicht-peptidischen Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung und Prävention der Alzheimer'schen Krankheit
EP97117677A EP0835659B1 (de) 1996-10-14 1997-10-13 Verwendung von nicht-peptidischen Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung und Prävention der Alzheimerischen Krankheit

Publications (1)

Publication Number Publication Date
DK0835659T3 true DK0835659T3 (da) 2005-04-18

Family

ID=26030327

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97117677T DK0835659T3 (da) 1996-10-14 1997-10-13 Anvendelse af ikke-peptidiske antagonister for bradykinin til fremstilling af lægemidler til behandling og forebyggelse af Alzheimer's sygdom

Country Status (9)

Country Link
US (1) US5952346A (da)
EP (1) EP0835659B1 (da)
JP (1) JP4189045B2 (da)
AT (1) ATE284692T1 (da)
DE (1) DE59712118D1 (da)
DK (1) DK0835659T3 (da)
ES (1) ES2230581T3 (da)
PT (1) PT835659E (da)
SI (1) SI0835659T1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19642289A1 (de) * 1996-10-14 1998-04-16 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung und Prävention der Alzheimer'schen Krankheit
US6153652A (en) 1996-11-22 2000-11-28 Elan Pharmaceuticals, Inc. N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
DE19712960A1 (de) * 1997-03-27 1998-10-01 Hoechst Ag Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten
JPH10301492A (ja) 1997-04-23 1998-11-13 Sony Corp 暗号化装置および方法、復号装置および方法、並びに情報処理装置および方法
US20030165481A1 (en) * 2000-02-24 2003-09-04 Hersh Louis B. Amyloid peptide inactivating enzyme to treat Alzheimer's disease
US20030083277A1 (en) * 2000-02-24 2003-05-01 Hersh Louis B. Use of insulin degrading enzyme (IDE) for the treatment of alzheimer's disease in patients
EP1914236A1 (en) 2002-04-10 2008-04-23 Ortho-McNeil Pharmaceutical, Inc. Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
AU2002950217A0 (en) 2002-07-16 2002-09-12 Prana Biotechnology Limited 8- Hydroxy Quinoline Derivatives
US8309562B2 (en) * 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
US7618975B2 (en) * 2003-07-03 2009-11-17 Myriad Pharmaceuticals, Inc. 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
WO2006026426A2 (en) 2004-08-27 2006-03-09 University Of Kentucky Research Foundation Amyloid peptide inactivating enzyme to treat alzheimer’s disease peripherally
CA2592900A1 (en) 2005-01-03 2006-07-13 Myriad Genetics Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
US8258145B2 (en) * 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
JP2009527562A (ja) * 2006-02-21 2009-07-30 アムゲン インコーポレイティッド ホスホジエステラーゼ１０阻害剤としてのシンノリン誘導体
CA2644850A1 (en) * 2006-03-08 2007-09-13 Amgen Inc. Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
DE102006015140A1 (de) * 2006-03-31 2007-10-11 Philipps-Universität Marburg Heterozyklische Verbindungen mit Wirkung gegen neurodegenerative Erkrankungen
KR20090079914A (ko) * 2006-09-29 2009-07-22 그뤼넨탈 게엠베하 치환된 설폰아미드 유도체

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385915A (en) * 1990-05-16 1995-01-31 The Rockefeller University Treatment of amyloidosis associated with Alzheimer disease using modulators of protein phosphorylation
US5212182A (en) * 1990-10-03 1993-05-18 American Home Products Corpooration Substituted quinolinyl- and naphthalenylbenzamides or benzylamines and related compounds useful as analgesics
US5216165A (en) * 1990-10-03 1993-06-01 American Home Products Corporation N-substituted aminoquinolines as analgesic agents
US5438064A (en) * 1991-12-23 1995-08-01 American Home Products Corporation Derivatives of 4-anilinoquinoline-3-carboxamide as analgesic agents
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
WO1996004251A1 (fr) * 1994-08-03 1996-02-15 Fujisawa Pharmaceutical Co., Ltd. Compose heterocyclique
KR970707098A (ko) * 1994-10-27 1997-12-01 후지야마 아키라 브라디키닌 길항제로서 피리도피리미돈, 퀴놀린 및 융합된 N-헤테로사이클(Pyridopyrimidones, quinolines and fused N-heterocycles as bradykinin antagonists)
WO1997032585A1 (en) * 1996-03-05 1997-09-12 Medinox, Inc. Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor

Also Published As

Publication number Publication date
ES2230581T3 (es) 2005-05-01
SI0835659T1 (en) 2005-06-30
EP0835659A1 (de) 1998-04-15
DE59712118D1 (de) 2005-01-20
US5952346A (en) 1999-09-14
ATE284692T1 (de) 2005-01-15
JPH10130144A (ja) 1998-05-19
JP4189045B2 (ja) 2008-12-03
EP0835659B1 (de) 2004-12-15
PT835659E (pt) 2005-03-31

Similar Documents

Publication Publication Date Title
DK0835659T3 (da) Anvendelse af ikke-peptidiske antagonister for bradykinin til fremstilling af lægemidler til behandling og forebyggelse af Alzheimer's sygdom
NO2010007I2 (no) N-(IS)-3-I3-isopropyl-5-metyl-4H-1,2,4-triasol-4-yl)-exo-8-azabicyklo[3.2.1]okt-8-yl]-1-fenylpropyl-4,4-difluorcykloheksankarboksamid
AP2002002603A0 (en) 3-aminoquinazolin-2,4-dione antibacterial agents.
TW200510431A (en) Quinazoline derivatives
SE0104332D0 (sv) Therapeutic agents
GB0124933D0 (en) Chemical compounds
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
NO20025821L (no) 2-aminokarbonyl-9H-purinderivater
TNSN05069A1 (fr) Derives de la quinolyl propyl piperidine et leur utilisation en tant qu'agents antimicrobiens
WO2001038324A3 (en) Imidazole derivatives and their use as raf kinase inhibitors
ATE227277T1 (de) Isoxazoline derivate und ihre verwendung als antimikroben
AU2003250206A1 (en) Herbicidal agents containing benzoylpyrazoles and safeners
WO2001032652A3 (en) N-substituted carbamoyloxyalkyl-azolium derivatives
MXPA03009750A (es) Compuestos quimicos.
MXPA03007142A (es) Derivados de carbolina.
MXPA04005027A (es) Preventivos o remedios para la enfermedad de alzheimer, o inhibidores de la formacion de fibrillas de proteina amiloide, que incluyen un compuesto heteroarilo que contiene nitrogeno.
HUP0400165A2 (hu) Benzoilpirazolokat és antidótumokat tartalmazó herbicid szerek
AP9901578A0 (en) Sulfonylbenzene compounds as anti-inflammatory/analgesic agents.
CA2412596A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
ATE360422T1 (de) Tetrazyklische verbindungen als pde5-inhibitoren
HUP0302518A2 (hu) Fungicid keverékek benzofenonokból és N-bifenil-nikotinamidokból
ATE176235T1 (de) Verwendung von cephem-derivaten als antimetastatische mittel
HUP0200072A2 (hu) (3-Heterociklil-benzoil)-pirazolszármazékok
ES2158809A1 (es) Nuevos derivados sulfonados como inhibidores de la ciclooxigenasa ii.
EP1023062A4 (en) ANTIBACTERIAL CARBAPENEMAS, COMPOSITIONS AND METHODS OF TREATMENT